Journal article 1704 views
Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk
Human Reproduction, Volume: 29, Issue: 9, Pages: 2041 - 2049
Swansea University Authors: Emma Rees , Gareth Dunseath , Steve Luzio , Julian Halcox
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1093/humrep/deu180
Abstract
Some studies have found that young women with polycystic ovary syndrome (PCOS) have increased measures of cardiovascular (CV) risk. However, PCOS is associated with insulin resistance (IR) and obesity which are themselves associated with increased risk of CV disease. Therefore in this population it...
Published in: | Human Reproduction |
---|---|
Published: |
2014
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa18319 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2014-09-08T01:58:20Z |
---|---|
last_indexed |
2018-02-09T04:52:49Z |
id |
cronfa18319 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>18319</id><entry>2014-09-07</entry><title>Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk</title><swanseaauthors><author><sid>bbbbb83ad6562465984718fe10f47e47</sid><ORCID>0000-0002-5373-1005</ORCID><firstname>Emma</firstname><surname>Rees</surname><name>Emma Rees</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>fccbba9edcaee08a839a3c5cff8cbe19</sid><ORCID>0000-0001-6022-862X</ORCID><firstname>Gareth</firstname><surname>Dunseath</surname><name>Gareth Dunseath</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>01491e1cd582746a654fad9addf0de16</sid><ORCID>0000-0002-7206-6530</ORCID><firstname>Steve</firstname><surname>Luzio</surname><name>Steve Luzio</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>3676f695eeda169d0f8c618adf27c04b</sid><ORCID>0000-0001-6926-2947</ORCID><firstname>Julian</firstname><surname>Halcox</surname><name>Julian Halcox</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2014-09-07</date><deptcode>HEAL</deptcode><abstract>Some studies have found that young women with polycystic ovary syndrome (PCOS) have increased measures of cardiovascular (CV) risk. However, PCOS is associated with insulin resistance (IR) and obesity which are themselves associated with increased risk of CV disease. Therefore in this population it is difficult to establish how much of the risk is due to IR and obesity rather than PCOS per se and this may have implications for management of the syndrome. We conducted a cross-sectional study to determine whether subclinical CV dysfunction in young women with PCOS is independent of the effects of obesity. 84 women with PCOS (Rotterdam criteria) and 95 healthy volunteers (16-45 years) were enrolled in the study and underwent detailed assessment of body composition, endocrinology status, arterial and cardiac function. Methods included computed tomography assessment of visceral fat, arterial tonometry measures of stiffness, carotid ultrasound measures of intima-media thickness and echocardiographic measures of diastolic function. After adjustment for age and body mass index, PCOS subjects had greater insulin response following glucose challenge and higher testosterone levels but similar measures of arterial stiffness, carotid intima-media thickness and diastolic function. PCOS subjects had unexpectedy higher levels of high-molecular weight adiponectin (thought to be cardio-protective) but there was no significant relationship between adiponectin and arterial stiffness or diastolic function. Central arterial stiffness and diastolic dysfunction are associated with both IR and obesity in young women but PCOS does not appear to confer additional risk. Therefore obesity represents the greatest modifiable risk factor for CV disease in young women with PCOS and lifestyle measures which target weight reduction are critical in the management of the syndrome.</abstract><type>Journal Article</type><journal>Human Reproduction</journal><volume>29</volume><journalNumber>9</journalNumber><paginationStart>2041</paginationStart><paginationEnd>2049</paginationEnd><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic/><keywords>PCOS, insulin resistance, obesity, cardiovascular</keywords><publishedDay>17</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2014</publishedYear><publishedDate>2014-07-17</publishedDate><doi>10.1093/humrep/deu180</doi><url/><notes/><college>COLLEGE NANME</college><department>Healthcare Science</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HEAL</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2023-06-26T16:56:14.4961541</lastEdited><Created>2014-09-07T11:22:57.5992301</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Emma</firstname><surname>Rees</surname><orcid>0000-0002-5373-1005</orcid><order>1</order></author><author><firstname>R.</firstname><surname>Coulson</surname><order>2</order></author><author><firstname>F.</firstname><surname>Dunstan</surname><order>3</order></author><author><firstname>W. D.</firstname><surname>Evans</surname><order>4</order></author><author><firstname>H. L.</firstname><surname>Blundell</surname><order>5</order></author><author><firstname>S. D.</firstname><surname>Luzio</surname><order>6</order></author><author><firstname>G.</firstname><surname>Dunseath</surname><order>7</order></author><author><firstname>J. P.</firstname><surname>Halcox</surname><order>8</order></author><author><firstname>A. G.</firstname><surname>Fraser</surname><order>9</order></author><author><firstname>D. A.</firstname><surname>Rees</surname><order>10</order></author><author><firstname>Gareth</firstname><surname>Dunseath</surname><orcid>0000-0001-6022-862X</orcid><order>11</order></author><author><firstname>Steve</firstname><surname>Luzio</surname><orcid>0000-0002-7206-6530</orcid><order>12</order></author><author><firstname>Julian</firstname><surname>Halcox</surname><orcid>0000-0001-6926-2947</orcid><order>13</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
v2 18319 2014-09-07 Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk bbbbb83ad6562465984718fe10f47e47 0000-0002-5373-1005 Emma Rees Emma Rees true false fccbba9edcaee08a839a3c5cff8cbe19 0000-0001-6022-862X Gareth Dunseath Gareth Dunseath true false 01491e1cd582746a654fad9addf0de16 0000-0002-7206-6530 Steve Luzio Steve Luzio true false 3676f695eeda169d0f8c618adf27c04b 0000-0001-6926-2947 Julian Halcox Julian Halcox true false 2014-09-07 HEAL Some studies have found that young women with polycystic ovary syndrome (PCOS) have increased measures of cardiovascular (CV) risk. However, PCOS is associated with insulin resistance (IR) and obesity which are themselves associated with increased risk of CV disease. Therefore in this population it is difficult to establish how much of the risk is due to IR and obesity rather than PCOS per se and this may have implications for management of the syndrome. We conducted a cross-sectional study to determine whether subclinical CV dysfunction in young women with PCOS is independent of the effects of obesity. 84 women with PCOS (Rotterdam criteria) and 95 healthy volunteers (16-45 years) were enrolled in the study and underwent detailed assessment of body composition, endocrinology status, arterial and cardiac function. Methods included computed tomography assessment of visceral fat, arterial tonometry measures of stiffness, carotid ultrasound measures of intima-media thickness and echocardiographic measures of diastolic function. After adjustment for age and body mass index, PCOS subjects had greater insulin response following glucose challenge and higher testosterone levels but similar measures of arterial stiffness, carotid intima-media thickness and diastolic function. PCOS subjects had unexpectedy higher levels of high-molecular weight adiponectin (thought to be cardio-protective) but there was no significant relationship between adiponectin and arterial stiffness or diastolic function. Central arterial stiffness and diastolic dysfunction are associated with both IR and obesity in young women but PCOS does not appear to confer additional risk. Therefore obesity represents the greatest modifiable risk factor for CV disease in young women with PCOS and lifestyle measures which target weight reduction are critical in the management of the syndrome. Journal Article Human Reproduction 29 9 2041 2049 PCOS, insulin resistance, obesity, cardiovascular 17 7 2014 2014-07-17 10.1093/humrep/deu180 COLLEGE NANME Healthcare Science COLLEGE CODE HEAL Swansea University 2023-06-26T16:56:14.4961541 2014-09-07T11:22:57.5992301 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Emma Rees 0000-0002-5373-1005 1 R. Coulson 2 F. Dunstan 3 W. D. Evans 4 H. L. Blundell 5 S. D. Luzio 6 G. Dunseath 7 J. P. Halcox 8 A. G. Fraser 9 D. A. Rees 10 Gareth Dunseath 0000-0001-6022-862X 11 Steve Luzio 0000-0002-7206-6530 12 Julian Halcox 0000-0001-6926-2947 13 |
title |
Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk |
spellingShingle |
Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk Emma Rees Gareth Dunseath Steve Luzio Julian Halcox |
title_short |
Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk |
title_full |
Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk |
title_fullStr |
Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk |
title_full_unstemmed |
Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk |
title_sort |
Central arterial stiffness and diastolic function are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk |
author_id_str_mv |
bbbbb83ad6562465984718fe10f47e47 fccbba9edcaee08a839a3c5cff8cbe19 01491e1cd582746a654fad9addf0de16 3676f695eeda169d0f8c618adf27c04b |
author_id_fullname_str_mv |
bbbbb83ad6562465984718fe10f47e47_***_Emma Rees fccbba9edcaee08a839a3c5cff8cbe19_***_Gareth Dunseath 01491e1cd582746a654fad9addf0de16_***_Steve Luzio 3676f695eeda169d0f8c618adf27c04b_***_Julian Halcox |
author |
Emma Rees Gareth Dunseath Steve Luzio Julian Halcox |
author2 |
Emma Rees R. Coulson F. Dunstan W. D. Evans H. L. Blundell S. D. Luzio G. Dunseath J. P. Halcox A. G. Fraser D. A. Rees Gareth Dunseath Steve Luzio Julian Halcox |
format |
Journal article |
container_title |
Human Reproduction |
container_volume |
29 |
container_issue |
9 |
container_start_page |
2041 |
publishDate |
2014 |
institution |
Swansea University |
doi_str_mv |
10.1093/humrep/deu180 |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
0 |
active_str |
0 |
description |
Some studies have found that young women with polycystic ovary syndrome (PCOS) have increased measures of cardiovascular (CV) risk. However, PCOS is associated with insulin resistance (IR) and obesity which are themselves associated with increased risk of CV disease. Therefore in this population it is difficult to establish how much of the risk is due to IR and obesity rather than PCOS per se and this may have implications for management of the syndrome. We conducted a cross-sectional study to determine whether subclinical CV dysfunction in young women with PCOS is independent of the effects of obesity. 84 women with PCOS (Rotterdam criteria) and 95 healthy volunteers (16-45 years) were enrolled in the study and underwent detailed assessment of body composition, endocrinology status, arterial and cardiac function. Methods included computed tomography assessment of visceral fat, arterial tonometry measures of stiffness, carotid ultrasound measures of intima-media thickness and echocardiographic measures of diastolic function. After adjustment for age and body mass index, PCOS subjects had greater insulin response following glucose challenge and higher testosterone levels but similar measures of arterial stiffness, carotid intima-media thickness and diastolic function. PCOS subjects had unexpectedy higher levels of high-molecular weight adiponectin (thought to be cardio-protective) but there was no significant relationship between adiponectin and arterial stiffness or diastolic function. Central arterial stiffness and diastolic dysfunction are associated with both IR and obesity in young women but PCOS does not appear to confer additional risk. Therefore obesity represents the greatest modifiable risk factor for CV disease in young women with PCOS and lifestyle measures which target weight reduction are critical in the management of the syndrome. |
published_date |
2014-07-17T16:56:09Z |
_version_ |
1769781298074746880 |
score |
11.037275 |